EPAS1 and acute myeloid leukemia: In this research, we aimed to determine whether EPAS1 could serve as a prognostic marker to guide clinical decision-making in AML and explore the role of EPAS1 in AML disease mechanism, which is the key to identify novel diagnostic and therapeutic avenues.